LIMK1/TPPP1/HDAC6 is a dual actin and microtubule regulatory complex that promotes drug resistance
Advances in Bioscience and Biotechnology (2014)
Ahmed T Negmeldin et al.
European journal of medicinal chemistry, 143, 1790-1806 (2017-11-19)
Histone deacetylase (HDAC) enzymes govern the post-translational acetylation state of lysine residues on protein substrates, leading to regulatory changes in cell function. Due to their role in cancers, HDAC proteins have emerged as promising targets for cancer treatment. Four HDAC...
Jehad Almaliti et al.
Journal of medicinal chemistry, 59(23), 10642-10660 (2016-11-05)
A number of analogues of the marine-derived histone deacetylase inhibitor largazole incorporating major structural changes in the depsipeptide ring were synthesized. Replacing the thiazole-thiazoline fragment of largazole with a bipyridine group gave analogue 7 with potent cell growth inhibitory activity...
HDAC6 activity is a non-oncogene addiction hub for inflammatory breast cancers.
Breast Cancer Research, 17(1), 149-149 (2015)
Down-regulation of deacetylase HDAC6 inhibits the melanoma cell line A375.S2 growth through ROS-dependent mitochondrial pathway.
PLoS ONE, 10(3), e0121247-e0121247 (2015)